Variable
|
Modality/statistics
|
Total (N = 243)
|
No Sepsis (N = 190)
|
Sepsis (N = 53)
|
p value
|
---|
Gender
|
F
|
90/243 (37%)
|
77/190 (41%)
|
13/53 (25%)
|
0.0331
|
M
|
153/243 (63%)
|
113/190 (59%)
|
40/53 (75%)
|
Age
|
Median (Q1;Q3)
|
65.0 (54.0;73.0)
|
65 (54;72)
|
64 (55;73)
|
0.9152
|
SOFA score
|
Median (Q1;Q3)
|
6 (5;9)
|
6 (4;9)
|
7 (5;9)
|
0.0402
|
Charlson score
|
0
|
51/243 (21%)
|
46/190 (24%)
|
5/53 (9%)
|
0.0551
|
1–2
|
84/243 (35%)
|
60/190 (32%)
|
24/53 (45%)
|
3–4
|
47/243 (19%)
|
34/190 (18%)
|
13/53 (25%)
|
5 and more
|
52/243 (21%)
|
42/190 (22%)
|
10/53 (19%)
|
Non-reported Charlson score
|
9/243 (4%)
|
8/190 (4%)
|
1/53 (2%)
|
Reason for ICU admission
|
CNS (trauma, stroke, haemorrhage)
|
94/243 (39%)
|
74/190 (39%)
|
20/53 (38%)
|
0.6573
|
Cardiovascular
|
76/243 (31%)
|
60/190 (32%)
|
16/53 (30%)
|
Abdominal/digestive
|
45/243 (19%)
|
32/190 (17%)
|
13/53 (25%)
|
Respiratory
|
18/243 (7%)
|
16/190 (8%)
|
2/53 (4%)
|
Metabolic
|
9/243 (4%)
|
7/190 (4%)
|
2/53 (4%)
|
ICU treatments
|
Mechanical ventilation
|
187/243 (77%)
|
143/190 (75%)
|
44/53 (83%)
|
0.2361
|
Vasopressors
|
95/243 (39%)
|
69/190 (36%)
|
26/53 (49%)
|
0.1751
|
No-reported vasopressors
|
16/243 (7%)
|
15/190 (8%)
|
1/53 (2%)
| |
Comorbidities
|
Cancer
|
40/243 (16%)
|
33/190 (17%)
|
7/53 (13%)
|
0.4301
|
Heart disease
|
35/243 (14%)
|
26/190 (14%)
|
9/53 (17%)
|
0.5901
|
Pulmonary disease
|
31/243 (13%)
|
26/190 (14%)
|
5/53 (9%)
|
0.3811
|
Renal disease
|
29/243 (12%)
|
23/190 (12%)
|
6/53 (11%)
|
0.8321
|
Liver disease
|
17/243 (7%)
|
12/190 (6%)
|
5/53 (9%)
|
0.5433
|
ICU length of stay
|
Median (Q1;Q3)
|
9 (6;17)
|
7 (5;13)
|
21 (14;27)
|
< 0.0012
|
- The following tests were performed: 1Chi2; 2Wilcoxon; 3Fisher’s exact. Statistical significance was set a p value ≤ 0.05
- ICU intensive care unit, IQR interquartile range, SOFA sequential organ failure assessment, CNS central nervous system